ARUP's Laboratory Test Directory

Congenital Adrenal Hyperplasia Treatment Panel : 2002029

Mnemonic: CAH RX PANEL

Ordering Recommendation: Use to monitor treatment of individuals with congenital adrenal hyperplasia.
Methodology: Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed: Sun-Sat
Reported: 1-4 days
Specimen Required: Patient Prep: Collect between 6-10 a.m.

Collect: Serum separator tube or green (sodium or lithium heparin). Also acceptable: Lavender (EDTA).

Specimen Preparation: Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min 0.5 mL)

Storage/Transport Temperature: Refrigerated.

Stability (collection to initiation of testing): Ambient: 24 hours; Refrigerated: 1 week; Frozen: 6 months
Reference Interval:
Test Number Components Reference Interval
2001638Androstenedione Effective November 14, 2011
Age Female Male
Premature Infants, 26-28 weeks-Day 4
Premature Infants, 31-35 weeks-Day 4
Full-term Infants, 1-7 days
8-30 days
1-5 months
6-24 months
2-3 years
4-5 years
6-7 year
8-9 years
10-11 years
12-13 years
14-15 years
16-17 years
18-39 years
40 years and older
Pre-menopausal
Postmenopausal 		0.92-2.82 ng/mL
0.80-4.46 ng/mL
0.20-2.90 ng/mL
0.18-0.80 ng/mL
0.06-0.68 ng/mL
Less than 0.15 ng/mL
Less than 0.16 ng/mL
0.02-0.21 ng/mL
0.02-0.28 ng/mL
0.04-0.42 ng/mL
0.09-1.23 ng/mL
0.24-1.73 ng/mL
0.39-2.00 ng/mL
0.35-2.12 ng/mL
0.26-2.14 ng/mL
0.13-0.82 ng/mL
0.26-2.14 ng/mL
0.13-0.82 ng/mL 		0.92-2.82 ng/mL
0.80-4.46 ng/mL
0.20-2.90 ng/mL
0.18-0.80 ng/mL
0.06-0.68 ng/mL
0.03-0.15 ng/mL
Less than 0.11 ng/mL
0.02-0.17 ng/mL
0.01-0.29 ng/mL
0.03-0.30 ng/mL
0.07-0.39 ng/mL
0.10-0.64 ng/mL
0.18-0.94 ng/mL
0.30-1.13 ng/mL
0.33-1.34 ng/mL
0.23-0.89 ng/mL
Tanner Stage I
Tanner Stage II
Tanner Stage III
Tanner Stage IV-V 		0.05-0.51 ng/mL
0.15-1.37 ng/mL
0.37-2.24 ng/mL
0.35-2.05 ng/mL 		0.04-0.32 ng/mL
0.08-0.48 ng/mL
0.14-0.87 ng/mL
0.27-1.07 ng/mL
009233217-Hydroxyprogesterone Quantitative by LC-MS/MS, Serum or Plasma
Age Female Male
Premature (26-28 weeks) 124-841 ng/dL 124-841 ng/dL
Premature (29-35 weeks) 26-568 ng/dL 26-568 ng/dL
Full term Day 3 7-77 ng/dL 7-77 ng/dL
4 days-30 days 7-106 ng/dL
4 days-2 months Less than 200 ng/dL
1-5 months 13-106 ng/dL
3-5 months 3-90 ng/dL
6 months-1 year Less than or equal to 148 ng/dL Less than or equal to 148 ng/dL
2-3 years Less than or equal to 256 ng/dL Less than or equal to 228 ng/dL
4-6 years Less than or equal to 299 ng/dL Less than or equal to 208 ng/dL
7-9 years Less than or equal to 71 ng/dL Less than or equal to 63 ng/dL
10-12 years Less than or equal to 129 ng/dL Less than or equal to 79 ng/dL
13-15 years 9-208 ng/dL 9-140 ng/dL
16-17 years Less than or equal to 178 ng/dL 24-192 ng/dL
18 years and older Less than 207 ng/dL Less than 139 ng/dL
Follicular 15-70 ng/dL
Luteal 35-290 ng/dL
Tanner Stage I: Less than or equal to 74 ng/dL Less than or equal to 62 ng/dL
Tanner Stage II Less than or equal to 164 ng/dL Less than or equal to 104 ng/dL
Tanner Stage III 13-209 ng/dL Less than or equal to 151 ng/dL
Tanner Stage IV-V 7-170 ng/dL 20-173 ng/dL
0081058Testosterone, Females or Children Effective November 14, 2011
Serum Total Testosterone, Determined by LC-MS/MS
Female Male
Premature (26-28 weeks): 5-16 ng/dL
Premature (31-35 weeks): 5-22 ng/dL
Newborn: 20-64 ng/dL
1-5 months: Less than 20 ng/dL
6-24 months: Less than 9 ng/dL
2-3 years: Less than 20 ng/dL
4-5 years: Less than 30 ng/dL
6-7 years: Less than 7 ng/dL
8-9 years: 1-11ng/dL
10-11 years: 3-32 ng/dL
12-13 years: 6-50 ng/dL
14-15 years: 6-52 ng/dL
16-17 years: 9-58 ng/dL
18-39 years: 9-55 ng/dL
40-59 years: 9-55 ng/dL
60 years and older: 5-32 ng/dL
Premenopausal (Greater than 18 years): 9-55 ng/dL
Postmenopausal: 5-32 ng/dL
Tanner Stage I: 2-17 ng/dL
Tanner Stage II: 5-40 ng/dL
Tanner Stage III: 10-63 ng/dL
Tanner Stage IV-V: 11-62 ng/dL 		Premature (26-28 weeks): 59-125 ng/dL
Premature (31-35 weeks): 37-198 ng/dL
Newborn: 75-400 ng/dL
1-5 months: 14-363 ng/dL
6-24 months: Less than 37 ng/dL
2-3 years: Less than 15 ng/dL
4-5 years: Less than 19 ng/dL
6-7 years: Less than 13 ng/dL
8-9 years: 2-8 ng/dL
10-11 years: 2-165 ng/dL
12-13 years: 3-619 ng/dL
14-15 years: 31-733 ng/dL
16-17 years: 158-826 ng/dL
18-39 years: 300-1080 ng/dL
40-59 years: 300-890 ng/dL
60 years and older: 300-720 ng/dL
Tanner Stage I: 2-15 ng/dL
Tanner Stage II: 3-303 ng/dL
Tanner Stage III: 10-851 ng/dL
Tanner Stage IV-V: 162-847 ng/dL

Interpretive Data: Total testosterone values may not reflect optimal concentrations in all individuals. Free or bioavailable testosterone measurements may provide supportive information.

See Compliance Statement B: www.aruplab.com/CS
CPT Code(s): 82157; 83498; 84403
Cross References: 17-Hydroxyprogesterone (Congenital Adrenal Hyperplasia Treatment Panel), Androstenedione (Congenital Adrenal Hyperplasia Treatment Panel), Testosterone (Congenital Adrenal Hyperplasia Treatment Panel)